Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MEDICA16 is a selective agonist for GPR40 as well as a partial agonist for GPR120. MEDICA16, an ATP-citrate lyase inhibitor, significantly reduces intracellular TG content in gastrocnemius muscle with an increase in insulin sensitivity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 41.00 | |
5 mg | In stock | $ 97.00 | |
10 mg | In stock | $ 147.00 | |
25 mg | In stock | $ 313.00 | |
50 mg | In stock | $ 538.00 | |
100 mg | In stock | $ 778.00 | |
500 mg | In stock | $ 1,620.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 129.00 |
Description | MEDICA16 is a selective agonist for GPR40 as well as a partial agonist for GPR120. MEDICA16, an ATP-citrate lyase inhibitor, significantly reduces intracellular TG content in gastrocnemius muscle with an increase in insulin sensitivity. |
Synonyms | MEDICA 16 |
Molecular Weight | 342.51 |
Formula | C20H38O4 |
CAS No. | 87272-20-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3.42 mg/mL (10 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MEDICA16 87272-20-6 Endocrinology/Hormones GPCR/G Protein Metabolism Others GPR ATP Citrate Lyase ACLY antidiabetogenic MEDICA 16 antidiabetic skeletal Inhibitor ligands Free Fatty Acid Receptor insulin FFAR endogenous muscle inhibit MEDICA-16 inhibitor